Literature DB >> 1834188

A cerebral computed tomography study of patients with drug-induced psychoses.

G A Wiesbeck1, K L Taeschner.   

Abstract

Twelve male patients with chronic drug consumption including cannabis (ICD = 304.3) and morphine (ICD = 304.7), who required inpatient treatment for drug-induced paranoid hallucinatory states (ICD = 292.1) were investigated using computed tomography for macroscopic structural changes in the brain. The findings were compared with those in a control group of schizophrenic patients who did not consume drugs. The brain scans were measured and not show any significant morphological differences between the two groups.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1834188     DOI: 10.1007/bf02191147

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  7 in total

Review 1.  The chronic cerebral effects of cannabis use. I. Methodological issues and neurological findings.

Authors:  R C Wert; M L Raulin
Journal:  Int J Addict       Date:  1986-06

2.  Regional cerebral blood flow in long-term heavy cannabis use.

Authors:  K Tunving; S O Thulin; J Risberg; S Warkentin
Journal:  Psychiatry Res       Date:  1986-01       Impact factor: 3.222

Review 3.  The chronic cerebral effects of cannabis use. II. Psychological findings and conclusions.

Authors:  R C Wert; M L Raulin
Journal:  Int J Addict       Date:  1986-06

4.  Computed tomographic examination of heavy marijuana smokers.

Authors:  J Kuehnle; J H Mendelson; K R Davis; P F New
Journal:  JAMA       Date:  1977-03-21       Impact factor: 56.272

5.  Absence of cerebral atrophy in chronic cannabis users. Evaluation by computerized transaxial tomography.

Authors:  B T Co; D W Goodwin; M Gado; M Mikhael; S Y Hill
Journal:  JAMA       Date:  1977-03-21       Impact factor: 56.272

6.  [Psychopathology and differential diagnosis of so-called Cannabis psychoses].

Authors:  K L Täschner
Journal:  Fortschr Neurol Psychiatr       Date:  1983-07       Impact factor: 0.752

7.  Cerebral atrophy in young cannabis smokers.

Authors:  A M Campbell; M Evans; J L Thomson; M J Williams
Journal:  Lancet       Date:  1971-12-04       Impact factor: 79.321

  7 in total
  7 in total

Review 1.  Clinical implications and methodological challenges in the study of the neuropsychological correlates of cannabis, stimulant, and opioid abuse.

Authors:  Antonio Verdejo-García; Francisca López-Torrecillas; Carmen Orozco Giménez; Miguel Pérez-García
Journal:  Neuropsychol Rev       Date:  2004-03       Impact factor: 7.444

Review 2.  Neuropsychological consequences of opiate use.

Authors:  Staci A Gruber; Marisa M Silveri; Deborah A Yurgelun-Todd
Journal:  Neuropsychol Rev       Date:  2007-08-10       Impact factor: 7.444

Review 3.  The effect of cannabis on the brain: can it cause brain anomalies that lead to increased risk for schizophrenia?

Authors:  Lynn E DeLisi
Journal:  Curr Opin Psychiatry       Date:  2008-03       Impact factor: 4.741

Review 4.  Acute and non-acute effects of cannabis on brain functioning and neuropsychological performance.

Authors:  Raul Gonzalez
Journal:  Neuropsychol Rev       Date:  2007-09       Impact factor: 7.444

Review 5.  Structural and functional imaging studies in chronic cannabis users: a systematic review of adolescent and adult findings.

Authors:  Albert Batalla; Sagnik Bhattacharyya; Murat Yücel; Paolo Fusar-Poli; Jose Alexandre Crippa; Santiago Nogué; Marta Torrens; Jesús Pujol; Magí Farré; Rocio Martin-Santos
Journal:  PLoS One       Date:  2013-02-04       Impact factor: 3.240

Review 6.  The neuropsychopharmacology of cannabis: A review of human imaging studies.

Authors:  Michael A P Bloomfield; Chandni Hindocha; Sebastian F Green; Matthew B Wall; Rachel Lees; Katherine Petrilli; Harry Costello; M Olabisi Ogunbiyi; Matthijs G Bossong; Tom P Freeman
Journal:  Pharmacol Ther       Date:  2018-10-19       Impact factor: 12.310

Review 7.  The Construct of Medical and Non-Medical Marijuana-Critical Review.

Authors:  Andrzej Silczuk; Daria Smułek; Marcin Kołodziej; Julia Gujska
Journal:  Int J Environ Res Public Health       Date:  2022-02-27       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.